Acelyrin Shares Fall 11%, Programming Error Found in Arthritis Drug Trial
By Ben Glickman Shares of Acelyrin fell on Monday after the company said there was a programming error in its drug trial of a treatment for psoriatic...
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Ben Glickman Shares of Acelyrin fell on Monday after the company said there was a programming error in its drug trial of a treatment for psoriatic...
By Denny Jacob American depositary receipts of Alterity Therapeutics dived 31% to $1.64 following the raising of capital to provide ongoing funding to...
By Colin Kellaher Entrada Therapeutics shares slid on Wednesday after the biopharmaceutical company said the Food and Drug Administration wouldn't lift the...
Company halts study for blood-thinning drug, is told to pay $1.56 billion in lawsuit relating to weedkiller
By Chris Wack Landos Biopharma shares were up 10% to $4.31 after the company published positive safety, tolerability, pharmacokinetic and clinical efficacy...